Impact of abciximab on coronary restenosis in diabetic patients undergoing elective paclitaxel-eluting stent implantation. A prospective, randomized, placebo-controlled study.

De Luca, Leonardo

Impact of abciximab on coronary restenosis in diabetic patients undergoing elective paclitaxel-eluting stent implantation. A prospective, randomized, placebo-controlled study. [electronic resource] - Acute cardiac care 2008 - 93-9 p. digital

Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial

1748-2941

10.1080/17482940701747063 doi


Abciximab
Antibodies, Monoclonal--therapeutic use
Antineoplastic Agents, Phytogenic--therapeutic use
Coated Materials, Biocompatible
Coronary Angiography
Coronary Restenosis--complications
Diabetes Complications--blood
Double-Blind Method
Elective Surgical Procedures--methods
Female
Follow-Up Studies
Humans
Immunoglobulin Fab Fragments--therapeutic use
Male
Middle Aged
Myocardial Revascularization--instrumentation
Paclitaxel--therapeutic use
Platelet Aggregation Inhibitors--therapeutic use
Platelet Glycoprotein GPIIb-IIIa Complex--antagonists & inhibitors
Prospective Studies
Stents
Treatment Outcome